Cloud-based medical imaging quantification software
Neurocloud PET delivers quantitative PET analysis and PET/MRI or PET/CT co-registration in few minutes.
Quantitative evaluation is recommended to assist the nuclear medicine physician in reporting brain FDG-PET patterns in neurodegenerative conditions.
Neurocloud VOL provides fully automatic MRI brain segmentation and volumetric information against a database of more than 800 patients.
The quantification of atrophy is currently considered a valid biomarker for the diagnosis and evaluation of neurodegenerative diseases.
Neurocloud SISCOM automatizes SISCOM, a procedure showing more than 80% sensitivity according to literature.
Refractory epilepsy surgery demands highest as possible precision in the epileptogenic focus localization
Neurocloud intuitive yet comprehensive reports give you all the quantitative and visual information you need to focus on abnormal brain areas.
Work efficiently with imaging specialists to improve your diagnostic.
Neurocloud is compatible with any scanner and IT facilities.
Increase the efficiency of your current human & technical resources without upfront investments.
Fast upload of PET/SPECT/MR/CT images, totally secure, thanks to our image anonymization procedure
Neurocloud co-registers all the images provided by the user for an optimal visual analysis.
The image is quantified both in an atlas-based approach and using a voxel-by-voxel comparison against a database of healthy subjects.
In 5 minutes the doctor can evaluate the results online and get a complete report attached to the medical history
We offer tailored solutions for research studies and clinical trials that allow you to focus on what really matters. Centralize and standardize your image reporting and analysis in Neurocloud for more consistent and realiable results across sitess
Qubiotech is an authorized medical devices manufacturer with advanced expertise in medical imaging software development and clinical information analysis. Tell us about your project and we will be happy to help you!
Qubiotech has a skilled R+D team with a solid publication track record of high impact factor papers. We are active players in national and European projects in the field of neuroimaging. We are open to join consortiums for developing medical imaging projects.
H. Clinic of Barcelona
Hospital of Logroño
Written 16 days ago
Qubiotech awarded the II Qubiotech Neuroimaging Prize during the SEMNIM 2019 Conference
Written 17 days ago
Qubiotech has closed a round of financing by including in its shareholding the parent company of the Servicio Movil group, also a 100% Galician capital firm and leader in logistics services and document management in the healthcare sector in Spain.
Written 46 days ago
Qubiotech will be present at the new BIoga Board of Directors until 2021, elected at the XIV Bioga General Assembly.